A phase 1, first-in-human, multicenter, open-label, dose escalation and dose-expansion study of single-agent ISB 2001 in subjects with relapsed/refractory multiple myeloma.
A phase II, randomized, open-label study evaluating efficacy and safety of new molecule compared with fulvestrant, both combined with a CDK4/6 inhibitor, in patients with estrogen receptor-positive, HER2-negative advanced breast cancer with resistance to prior adjuvant endocrine therapy.
A study providing immunotherapy and chemotherapy treatment along with surgery for women with a specific type of early or locally advanced breast cancer.
A trial looking at how a special type of immune cell behaves in people with cancers or lymphomas that are recurrent or relapsed or didn’t respond to treatment.
A first-time human study to test the safety and right dose of a new drug for people with a blood cancer that has relapsed or didn’t respond to earlier treatment.
A study testing a new medicine in people with advanced cancers to see if it’s safe and how their body reacts to it.
A trial of an experimental oral novel drug that is for people with advanced cancers that have relapsed.
A real-world study observing how safe and helpful cellular therapy treatments are for patients with various cancers.
A research study looking at whether tiny bits of genetic material in the blood could help detect ovarian cancer.
A study to check how well and safely a new immunotherapy medicine works when used along with chemotherapy in patients with colon cancer that has spread.
A study comparing two hormone-based treatments, in people with a certain type of breast cancer.
A study checking the safety and effects of immunotherapy of an existing cancer medicine in people with head and neck cancer, either used alone or with chemo or radiation.
A study comparing a new cancer medicine with the original one in patients with a type of breast cancer that has spread.
A study testing a combination of a new immune-based tablet and standard treatments in people with advanced lung cancer to see if the mix works better.
A trial to see if a new medicine, used alone or with another, is safe and works in patients with solid cancers that didn’t respond to earlier immunotherapy treatments.
A study looking at the safety and effect of a new oral drug in people with specific blood cancers that have returned or resisted treatment.
A study testing how well a new medicine works in people with a specific type of stomach cancer that has spread.
A first-time study in humans to test the safety of a new oral treatment in patients with lymphoma that didn’t respond to earlier treatments.
A study comparing a newer version of a cancer medicine with the original one in people with head and neck cancer that came back after chemotherapy.
A review of past medical records to understand how patients with head and neck cancer responded to immune therapy in real-world situations.
